Marianne P. Allen

Array ( [id] => 3837770 [patent_doc_number] => 05846937 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Method of using exendin and GLP-1 to affect the central nervous system' [patent_app_type] => 1 [patent_app_number] => 8/811066 [patent_app_country] => US [patent_app_date] => 1997-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7065 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846937.pdf [firstpage_image] =>[orig_patent_app_number] => 811066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1365481 [patent_doc_number] => 06566092 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'DNA encoding a vertebrate homolog of hedgehog, Vhh-1, expressed by the notochord, and uses thereof' [patent_app_type] => B1 [patent_app_number] => 08/700393 [patent_app_country] => US [patent_app_date] => 1997-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 81 [patent_figures_cnt] => 166 [patent_no_of_words] => 46826 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566092.pdf [firstpage_image] =>[orig_patent_app_number] => 08700393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3953433 [patent_doc_number] => 05935781 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Apolipoprotein E polymorphism and treatment of Alzheimer\'s disease' [patent_app_type] => 1 [patent_app_number] => 8/727637 [patent_app_country] => US [patent_app_date] => 1997-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 25 [patent_no_of_words] => 7724 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935781.pdf [firstpage_image] =>[orig_patent_app_number] => 727637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3931517 [patent_doc_number] => 05939271 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'Netrin receptor' [patent_app_type] => 1 [patent_app_number] => 8/808982 [patent_app_country] => US [patent_app_date] => 1997-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9755 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939271.pdf [firstpage_image] =>[orig_patent_app_number] => 808982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4214298 [patent_doc_number] => 06087163 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Mycobacterium tuberculosis specific proteins and genes, mixtures of anitgens and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/796792 [patent_app_country] => US [patent_app_date] => 1997-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10331 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087163.pdf [firstpage_image] =>[orig_patent_app_number] => 796792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4023600 [patent_doc_number] => 05993811 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis' [patent_app_type] => 1 [patent_app_number] => 8/794740 [patent_app_country] => US [patent_app_date] => 1997-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 6175 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/993/05993811.pdf [firstpage_image] =>[orig_patent_app_number] => 794740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4128787 [patent_doc_number] => 06033875 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Method of improved production of insulin-like growth factor' [patent_app_type] => 1 [patent_app_number] => 8/789194 [patent_app_country] => US [patent_app_date] => 1997-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3810 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 233 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/033/06033875.pdf [firstpage_image] =>[orig_patent_app_number] => 789194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4268866 [patent_doc_number] => 06245564 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Method for separating cells' [patent_app_type] => 1 [patent_app_number] => 8/787788 [patent_app_country] => US [patent_app_date] => 1997-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 9082 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245564.pdf [firstpage_image] =>[orig_patent_app_number] => 787788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4129654 [patent_doc_number] => 06121004 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Autoantibodies and their targets in the diagnosis of peripheral neuropathies' [patent_app_type] => 1 [patent_app_number] => 8/783468 [patent_app_country] => US [patent_app_date] => 1997-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 26389 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121004.pdf [firstpage_image] =>[orig_patent_app_number] => 783468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1436137 [patent_doc_number] => 06355781 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Mammalian growth factor' [patent_app_type] => B1 [patent_app_number] => 08/775567 [patent_app_country] => US [patent_app_date] => 1996-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 38 [patent_no_of_words] => 10029 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355781.pdf [firstpage_image] =>[orig_patent_app_number] => 08775567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1323528 [patent_doc_number] => 06602689 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-05 [patent_title] => 'Fused DNA sequence, fused protein expressed from said fused DNA sequence and method for expressing said fused protein' [patent_app_type] => B1 [patent_app_number] => 08/778717 [patent_app_country] => US [patent_app_date] => 1996-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14165 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/602/06602689.pdf [firstpage_image] =>[orig_patent_app_number] => 08778717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4294303 [patent_doc_number] => 06235885 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Rat hedgehog protein-1 (Vhh-1)' [patent_app_type] => 1 [patent_app_number] => 8/757230 [patent_app_country] => US [patent_app_date] => 1996-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 43 [patent_no_of_words] => 17426 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235885.pdf [firstpage_image] =>[orig_patent_app_number] => 757230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4232684 [patent_doc_number] => 06074841 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'Don-1 gene and polypeptides and uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/753007 [patent_app_country] => US [patent_app_date] => 1996-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 7 [patent_no_of_words] => 33487 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/074/06074841.pdf [firstpage_image] =>[orig_patent_app_number] => 753007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4284464 [patent_doc_number] => 06210920 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Flea protease proteins, nucleic acid molecules, and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/749699 [patent_app_country] => US [patent_app_date] => 1996-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29232 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 333 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/210/06210920.pdf [firstpage_image] =>[orig_patent_app_number] => 749699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4238744 [patent_doc_number] => 06090781 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Stabilizing formulation for NGF' [patent_app_type] => 1 [patent_app_number] => 8/746073 [patent_app_country] => US [patent_app_date] => 1996-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 15436 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090781.pdf [firstpage_image] =>[orig_patent_app_number] => 746073 [rel_patent_id] =>[rel_patent_doc_number] =>)